We are happy to have been profiled in SvD, Sweden’s largest daily magazine. Read more about Sigrid on page 12 (in Swedish).
-In Sweden, we have good, public healthcarefor everyone, but that’s not how it looks in them
most other countries, there are only those rich who can afford insulin therapy.
We can not live in a world where we waiting for people to get sick and more end must be treated with insulin, says Sana Alajmovic, Co-Founder & CEO at Sigrid Therapeutics AB.
